Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

S Hoa; S Bernatsky; M Baron; S Proudman; W Stevens; J Sahhar; M Wang; RJ Steele; M Hudson; G Gyger; J Pope; M Larché; N Khalidi; A Masetto; E Sutton; TS Rodriguez-Reyna; N Maltez; C Thorne; PR Fortin; A Ikic; D Robinson; N Jones; S LeClercq; JP Mathieu; P Docherty; D Smith; M Fritzler; L Croyle; J de Jager; N Ferdowsi; C Hill; R Laurent; S Lester; G Major; K Morrisroe; P Nash; G Ngian; M Nikpour; M Rischmueller; J Roddy; L Schrieber; W Stevens; G Strickland; A Sturgess; V Thakkar; K Tymms; J Walker; P Youseff; J Zochling

Journal article

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

S Hoa, S Bernatsky, M Baron, S Proudman, W Stevens, J Sahhar, M Wang, RJ Steele, M Hudson, G Gyger, J Pope, M Larché, N Khalidi, A Masetto, E Sutton, TS Rodriguez-Reyna, N Maltez, C Thorne, PR Fortin, A Ikic Show all

Chest | ELSEVIER | Published : 2021

DOI: 10.1016/j.chest.2021.06.014

University of Melbourne Researchers

Dr Wendy Stevens Author

Dr Katie Morrisroe Author

Prof Mandana Nikpour Author

Related Projects (1)

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE: A COLLABORATIVE AND INTERDISCIPLINARY PROGRAM OF RESEARCH

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

Grants

Awarded by Scleroderma Foundation

Citation metrics

11Scopus

8Web of Science

11Dimensions

Keywords

Critical Care Medicine

Lung

Life Sciences & Biomedicine

Australian Scleroderma Interest Group (asig)

Scleroderma

Science & Technology

32 Biomedical and Clinical Sciences

Autoimmune Disease

Canadian Scleroderma Research Group (csrg)

Rare Diseases

Women'S Health

General & Internal Medicine

Respiratory

Respiratory System

3211 Oncology and Carcinogenesis